Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Specialty pharmaceutical company Warner Chilcott
So what: Despite receiving a decent boost from the products acquired in its Procter & Gamble
Now what: Even with today's miss, management said the overall integration of P&G's portfolio is going rather smoothly. Generic competition from the likes of Teva
Interested in more info on Warner Chilcott? Add it to your watchlist by clicking here.